United States Food and Drug Administration Approves Aridol
Links shared publicly online about this topic.
- 808total visits
United States Food and Drug Administration Approves Aridol
View full resource at drugs.com
Tags: Asthma, Lung, Diet and Nutrition, Drug, Clinical Trial, FDA, News
Most Recently Shared on October 11, 2010 at 11:12 pm By:
United States Food and Drug Administration Approves Aridol: Sydney, Australia - 6 October 2010 - Pharmaceuti... http://bit.ly/d3KPYi #drug
Botox Treatments for Urinary Incontinence in Seniors | The Intentional Caregiver
takingcareofthefolks.com — “Botox Treatments for Urinary Incontinence in Seniors The United States Food and Drug Administration approved” View full resource at takingcareofthefolks.com
Most Recently Shared on April 21, 2012 at 2:03 am By:
archives: : Botox Treatments for Urinary... http://t.co/lhmgVjTh
Government ponders heart safety trials for obesity drugs - Yahoo! News
news.yahoo.com — “From Yahoo! News: WASHINGTON (Reuters) - Health regulators are asking for advice on whether, and when, heart safety studies should be required for new obesity drugs, possibly adding a new hurdle on their path to approval. An advisory panel to the Food and Drug Administration will discuss this week whether regulators should mandate such trials before the drugs can be marketed in the United States. ...” View full resource at news.yahoo.com
Most Recently Shared on March 26, 2012 at 7:06 pm By:
Government ponders heart safety trials for obesity drugs - WASHINGTON (Reuters) - Health regulators are asking for a... http://t.co/MSNblCsb
Teva gets exclusive 180 days to market generic antidepressant and anti-anxiety pill Lexapro
news-medical.net — “Teva Pharmaceutical Industries Ltd. Has won U.S. approval to sell the first generic version of Lexapro for depression and anxiety. Teva has been granted a 180-day exclusivity, so no other firm can market the generic medication in the United States in that timeframe, the Food and Drug Administration (FDA) said in a news release.” View full resource at news-medical.net
Most Recently Shared on March 15, 2012 at 7:14 pm By:
Teva gets exclusive 180 days to market generic antidepressant and anti-anxiety pill Lexapro: Teva Pharmaceutical... http://t.co/XKefLRHt
EffRx receives FDA approval for BINOSTO to treat osteoporosis
news-medical.net — “EffRx Pharmaceuticals SA today announced that the U.S. Food and Drug Administration (FDA) has approved BINOSTO (alendronate sodium) Effervescent Tablets, previously known as EX101, for the treatment of osteoporosis in postmenopausal women, and as a treatment to increase bone mass in men with osteoporosis. EffRx anticipates that BINOSTO will be commercially available in the United States in the third quarter of 2012.” View full resource at news-medical.net
Most Recently Shared on March 15, 2012 at 4:26 am By:
Oncology News: EffRx receives FDA approval for BINOSTO to treat osteoporosis: EffRx Pharmaceuticals SA today ann... http://t.co/oNs9QvFc
FDA approves new supplies of drugs that are facing shortages
news-medical.net — “The United States Food and Drugs Administration (FDA) have approved new suppliers for two crucial cancer drugs, easing critical shortages that had been concerning patients and families particularly of the children with leukemia. But there are currently 283 separate prescription drugs in short supply or unavailable nationwide, and regulators and manufacturers say shortages are a long-term problem that will continue to scare patients and doctors.” View full resource at news-medical.net
Most Recently Shared on February 22, 2012 at 11:29 pm By:
Ovarian Cancer News: FDA approves new supplies of drugs that are facing shortages: The United States Food and Dr... http://t.co/655iWVM7
Bangor man is second person in the US to get neurostimulation device implanted to stop pain. - latimes.com
latimes.com — “St. Luke's Hospital: Jeff Hardick is second person in the United States to have neurostimulation device implanted after it receiving approval by the U.S. Food and Drug Administration in November.” View full resource at latimes.com
Most Recently Shared on January 9, 2012 at 5:37 pm By:
Bangor man second in U.S. to get anti-pain implant http://t.co/ExlhxAn3 via @LATimes
A landmark for children's health - Houston Chronicle
chron.com — “Recently, the United States Food and Drug Administration granted humanitarian device exemption for the Berlin Heart EXCOR Pediatric Ventricular Assist Device - the only pediatric mechanical circulatory support device designed specifically for infants and small children. [...] FDA approval, the device was only available to children in the U.S. through compassionate use solicitation, on a case-by-case basis. Small children awaiting heart transplantation where donor availability is limited face a w” View full resource at chron.com
Most Recently Shared on January 3, 2012 at 4:56 pm By:
RT @bcmhouston: Landmark event: FDA approves Berlin Heart for children with heart failure. http://t.co/NOpFIr10
Belotero Balance – Another Restylane? » Truth in Cosmetic Surgery
cosmeticsurgerytruth.com — “Merz Aesthetics announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Belotero Balance for the correction of...” View full resource at cosmeticsurgerytruth.com
Most Recently Shared on November 30, 2011 at 3:48 pm By:
Cos Surg Truth Blog Belotero Balance – Another Restylane?: Merz Aesthetics announced that the United States (U... http://t.co/F0j0ta1O
The HPV Vaccine: Access and Use in the U.S. - Kaiser Family Foundation
kff.org — “The Food and Drug Administration has approved two vaccines against infection by certain strains of human papillomavirus (HPV), the most common sexually transmitted infection in the United States. Initially, the vaccines were recommended only for girls and young women, but in 2011 the Centers for Disease Control and Prevention broadened them to include boys and young men. The fact sheet discusses HPV and cancers related to the virus, use of the HPV vaccines for both females and males, and insuran” View full resource at kff.org
Most Recently Shared on November 22, 2011 at 6:36 pm By:
HPV Vaccine Fact Sheet Discusses New Recommendation for Vaccinating Boys via KFF: http://t.co/4DpKQQdp
FDA Approves First Umbilical Cord Blood Product - Yahoo! News
news.yahoo.com — “From Yahoo! News: FRIDAY, Nov. 11 (HealthDay News) -- The first product in the United States that uses human umbilical cord stem cells to treat disorders of the hematopoietic (blood-forming) system has been approved by the Food and Drug Administration.” View full resource at news.yahoo.com
Most Recently Shared on November 12, 2011 at 7:02 am By:
FDA Approves First Umbilical Cord Blood Product - Yahoo! News http://t.co/ybfvM2FN via @YahooNews
Watson receives FDA approval for generic Kadian ANDA
news-medical.net — “Watson Pharmaceuticals, Inc. today announced that it has received approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for morphine sulfate extended-release capsules USP, the generic equivalent of Actavis' Kadian.” View full resource at news-medical.net
Most Recently Shared on November 11, 2011 at 5:17 am By:
Medicare News: Watson receives FDA approval for generic Kadian ANDA: Watson Pharmaceuticals, Inc. today announce... http://t.co/bq3BVrMo
Pioneering Stroke Spasticity Expert Welcomes FDA Approval of Botox® To Treat Upper Limb Spasticity Following Stroke - Wake Forest Baptist Medical Center
wakehealth.edu — “The announcement by the Food and Drug Administration (FDA) that it has approved Botox® (onabotulinumtoxinA) to treat upper limb spasticity (excessive muscle tightness) following a stroke is great news for the millions of stroke survivors in the United States, said Allison Brashear, M.D., professor and chair of the Department of Neurology at WFUBMC.” View full resource at wakehealth.edu
Most Recently Shared on September 13, 2011 at 8:07 pm By:
Dr. Brashear led a research study that resulted in a new treatment method for upper limb spasticity: Botox http://t.co/ihgvjiS
Allergan gets FDA nod for use of Botox in urinary incontinence
news-medical.net — “Allergan Inc. has received United States Food and Drug Administration (FDA) approval to market the wrinkle smoother Botox as a treatment for urinary incontinence. The FDA approved the drug for people with overactive bladders who have neurologic conditions such as multiple sclerosis and spinal cord injuries, the agency said today in a statement. The medicine is injected into the bladder to increase its capacity by relaxing muscles.” View full resource at news-medical.net
Most Recently Shared on August 25, 2011 at 10:18 pm By:
Allergan gets FDA nod for use of Botox in urinary incontinence: Allergan Inc. has received United States Food an... http://t.co/ANHoTem
FDA approves Allergan's BOTOX to treat specific form of urinary incontinence
news-medical.net — “Allergan, Inc. today announced the United States Food and Drug Administration (FDA) has approved BOTOX for injection for the treatment of urinary incontinence due to detrusor overactivity associated with a neurologic condition in adults who have an inadequate response to or are intolerant of an anticholinergic medication.” View full resource at news-medical.net
Most Recently Shared on August 25, 2011 at 10:30 am By:
FDA approves Allergan's BOTOX to treat specific form of urinary incontinence: Allergan, Inc. today announced the... http://t.co/l4VjvY6
FDA approves Allergan's BOTOX to treat specific form of urinary incontinence
news-medical.net — “Allergan, Inc. today announced the United States Food and Drug Administration (FDA) has approved BOTOX for injection for the treatment of urinary incontinence due to detrusor overactivity associated with a neurologic condition in adults who have an inadequate response to or are intolerant of an anticholinergic medication.” View full resource at news-medical.net
Most Recently Shared on August 25, 2011 at 5:25 am By:
Obesity News: FDA approves Allergan's BOTOX to treat specific form of urinary incontinence: Allergan, Inc. tod... http://t.co/PUWqG8S
Advertisement

